Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2019
DOI: 10.1007/s11936-019-0749-9
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic and Therapeutic Approach to Arrhythmias in Adult Congenital Heart Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 106 publications
0
3
0
Order By: Relevance
“…The incidence of AT in patients with congenital heart disease (CHD) is three times that in the general population, and 42% of structural heart disease is complicated with MAT ( 3 ). Furthermore, the morbidity of atrial arrhythmia is increased with aging and the complexity of CHD, both of which predict adverse outcomes of AT, such as heart failure, death, and intervention ( 7 ). Because of early diagnosis and early surgery, the prognosis of patients with CHD has greatly improved in recent decades.…”
Section: Etiology Of Mat At Different Periods Of Growthmentioning
confidence: 99%
See 1 more Smart Citation
“…The incidence of AT in patients with congenital heart disease (CHD) is three times that in the general population, and 42% of structural heart disease is complicated with MAT ( 3 ). Furthermore, the morbidity of atrial arrhythmia is increased with aging and the complexity of CHD, both of which predict adverse outcomes of AT, such as heart failure, death, and intervention ( 7 ). Because of early diagnosis and early surgery, the prognosis of patients with CHD has greatly improved in recent decades.…”
Section: Etiology Of Mat At Different Periods Of Growthmentioning
confidence: 99%
“…In previous studies, the main etiologies of MAT are gestational disease, Costello syndrome, congenital heart disease, post-cardiac surgery, cardiac anatomic abnormality, pulmonary arterial hypertension, and infectious diseases. Although the prognosis of pediatric MAT is favorable in most patients, adverse outcomes of MAT have been reported in some children, particularly the patients who are accompanied by HRAS, RYR2, RAF1, and RAS gene mutation ( 5 , 7 ). The adverse outcomes of MAT include cardiogenic death (3%), respiratory failure (6%), or persistent arrhythmia (7%).…”
Section: Introductionmentioning
confidence: 99%
“…20 Since the entire S-ICD system is implanted in an extra-thoracic space, it eliminates the complications related to endo-or epicardial leads. 21 The ACHD patients with no transvenous access to the heart (namely Fontal palliation), or those with a right-to-left shunt and increased risk of systemic emboli, can attain the utmost potential benefit 22 from implantation of S-ICD. Unfortunately, our study demonstrated that 40% of the contemporary complex ACHD population is ineligible for S-ICD.…”
Section: Nearly Half Of the Contemporary Achd Population Is Ineligible For S-icdmentioning
confidence: 99%